What does the Factor V Leiden Mutant Detection test include?
This test detects the G1691A mutation in the Factor V gene to assess predisposition to thrombophilia and clotting disorders.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated PCR-based methods under strict quality control to accurately identify the Factor V Leiden mutation.
Who should take this test?
Individuals with a personal or family history of recurrent blood clots, unexplained thrombosis, or pregnancy complications may be advised to take this test.
What sample type is required?
An EDTA-anticoagulated blood sample is required for precise and reliable genetic analysis.
Why is detecting Factor V Leiden important?
Identifying the mutation helps evaluate clotting risk, guide preventive measures, and inform treatment decisions for thrombophilia management.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows stringent quality control, validated PCR protocols, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No special preparation or fasting is required; patients should follow physician instructions for sample collection.
How soon are results available?
Turnaround time may vary, but Metropolis Healthcare typically provides timely reports to support clinical evaluation and management.